Plasma Cell dyscrasia
Showing 1 - 25 of >10,000
Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)
Not yet recruiting
- Lymphoma
- +2 more
- Web Application
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2022
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,
Completed
- Myelodysplastic Syndrome
- +13 more
- Fludarabine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022
AL Amyloidosis, Plasma Cell Dyscrasia Trial in Nanjing
Enrolling by invitation
- AL Amyloidosis
- Plasma Cell Dyscrasia
-
Nanjing, Jiangsu, ChinaNational Clinical Research Center of Kidney Diseases, Jinling Ho
Jan 26, 2021
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
Completed
- Plasma Cell Dyscrasia
- Monoclonal Gammopathy
-
Boston, MassachusettsTufts Medical Center
May 7, 2020
Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)
Recruiting
- Relapsed and/or Refractory Multiple Myeloma
- Plasma Cell Leukemia in Relapse
- Biological
-
Shanghai, Shanghai, ChinaShanghai Tongji Hospital
May 29, 2023
Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)
Recruiting
- Multiple Myeloma
- Plasma Cell Leukemia
- CT0594CP
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Apr 18, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)
Not yet recruiting
- Multiple Myeloma
- Primary Plasma Cell Leukemia
- Experimental: CAR-T cells Infusion
-
Shanghai, ChinaShanghai Changzheng Hospital
Apr 20, 2023
Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)
Recruiting
- Plasma Cell Leukemia
- anti-BCMA CAR-T
- VRD-based regimen
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia
- CAR-T (CAR-GPRC5D)
- (no location specified)
Feb 26, 2023
Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)
Recruiting
- Multiple Myeloma
- Plasma Cell Leukemia
- Human BCMA targeted CAR-NK cells injection
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Sep 13, 2023
Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)
Recruiting
- Plasma Cell Leukemia
- anti-BCMA CAR-T
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023
Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
Recruiting
- Endometrial Cancer
- low-depth whole-genome sequencing technology
-
Guangzhou, Guangdong, ChinaThe Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 9, 2023
Thrombosis in Multiple Myeloma in an University Medical Center
Recruiting
- Multiple Myeloma
- +2 more
- Multiple myeloma
-
Groningen, NetherlandsUniversity Medical Center Groningen
Sep 12, 2022
Multiple Myeloma Trial in Wuhan (SENL103)
Recruiting
- Multiple Myeloma
- SENL103
-
Wuhan, Hubei, ChinaTongji Hospital
Sep 27, 2023
COVID-19, Hematopoietic Stem Cell Transplantation Trial in Tianjin (COVID Convalescent Plasma)
Recruiting
- COVID-19
- Hematopoietic Stem Cell Transplantation
- COVID Convalescent Plasma
-
Tianjin, None Selected, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jun 13, 2023
Melanoma, NSCLC Trial (Evaluation of ctDNA using the F1T after 1 year of immunotherapy)
Not yet recruiting
- Melanoma
- Non-small Cell Lung Cancer
- Evaluation of ctDNA using the F1T after 1 year of immunotherapy
- (no location specified)
Nov 24, 2023
Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics
Recruiting
- Ovarian Cancer
-
Guangzhou, Guangdong, ChinaThe Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jan 12, 2023
Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics
Active, not recruiting
- Ovarian Cancer
-
Guangzhou, Guangdong, ChinaThe Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jan 12, 2023
Healthy Trial (blood sampling)
Not yet recruiting
- Healthy
- blood sampling
- (no location specified)
Apr 20, 2023
PLAsma Genomic Testing in Advanced Non-Small Cell Lung Cancer:
Not yet recruiting
- Non-small Cell Lung Cancer
- ctDNA liquid biopsy - Roche Avenio Assay
- (no location specified)
Sep 14, 2022
RRMM, Other Plasma Cell Diseases Trial (LM-305, Dexamethasone)
Not yet recruiting
- RRMM
- Other Plasma Cell Diseases
- (no location specified)
Dec 1, 2022
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia
- CAR-T (CAR-GPRC5D)
-
Wuhan, Hu Bei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022
Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
Not yet recruiting
- Lymphoma, B-Cell
- +6 more
- Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
-
Guayaquil, Guayas, EcuadorInstituto Oncológico Nacional Dr. Juan Tanca Marengo
Apr 27, 2023